Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PTC Adds To Management Team In Sign Of Progress Beyond Setbacks

This article was originally published in The Pink Sheet Daily

Executive Summary

The New Jersey-based biotech has not lost its optimism after a setback in Europe for its lead product and is showing growth in other areas.

Advertisement

Related Content

Sarepta Continues To Show Results In DMD, But Is It Enough?
Sarepta Continues To Show Results In DMD, But Is It Enough?
Prosensa Finds Path Forward For Drisapersen In DMD Drug Revival
Prosensa Finds Path Forward For Drisapersen In DMD Drug Revival
Isis Moves SMA Drug Forward As Market Interest For The Rare Disease Expands
Cystic Fibrosis Market Snapshot: Disease-Modifying Drugs Elusive 24 Years After Discovery Of Root Cause
Roche Inks A Second Deal With PTC Therapeutics, Pays $30M Upfront

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS076432

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel